The FDA has just approved the first-ever Respiratory Syncvtial Virus (RSV) vaccine for pregnant mothers.
The shots are supposed to help infants up to 6 months old fight the cold-like virus. The next step is for the CDC to study and issue recommendations for the vaccine. According to HUFFPOST, in clinical trials the shots didn’t prevent RSV, yet “proved 82% effective at preventing a severe case during babies’ first three months.”
In October 2022, Dr. Juan Salazar of Connecticut Children’s Hospital, where RSV has caused a shuffling of patients into playrooms and other spaces not normally used for beds, called RSV “an emergency” that needed addressing immediately.
Cases had died down during the pandemic but are now set to surge as post-pandemic life returns to normal, he said. Pfizer, maker of the vaccine, said they believe if the shots are approved soon, this season’s RSV surge might be contained.
SOURCES:
Source: Original Article
Publish Date: 2023-08-22 16:18:03